Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex

Isabel S Griffin1, Dallas J Smith2, Pallavi Annambhotla1

  • 1Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Abstract

Insights

Antifungal prophylaxis may prevent fungal infections in organ transplant recipients from donors with Fusarium meningitis. This study monitored recipients for infection after transplantation, finding no invasive fusariosis in those receiving prophylaxis.

Area of Science:

  • Infectious Diseases
  • Transplant Surgery
  • Mycology

Background:

  • A deceased organ donor was linked to a fungal meningitis outbreak following epidural anesthesia in Mexico.
  • The donor's organs were transplanted into five recipients across four US states.

Purpose of the Study:

  • To assess the risk of donor-derived fungal infections in organ transplant recipients.
  • To evaluate the effectiveness of antifungal prophylaxis in preventing such infections.

Main Methods:

  • Donor cerebrospinal fluid and plasma were analyzed using metagenomic next-generation sequencing (mNGS) and PCR, identifying Fusarium solani species complex.
  • Organ recipients received voriconazole prophylaxis and were monitored for infection signs and serum (1-3)-β-d-glucan levels.

Main Results:

  • Four of five recipients received voriconazole prophylaxis and were monitored weekly.
  • No recipient developed signs or symptoms of fusariosis; one liver recipient experienced graft failure unrelated to fungal infection.

Conclusions:

  • Antifungal prophylaxis may be beneficial in preventing donor-derived Fusarium infections in organ transplant recipients.
  • Early detection and prophylactic treatment are crucial in managing potential infections from contaminated donor organs.